Clinical study on Chonglian Oral Liquid combined with anti-infection in the treatment of adult community-acquired pneumonia
Objective To observe the clinical therapeutic effect and clinical adverse reactions of Chonglian Oral Liquid combined with anti-infection in patients with adult community acquired pneumonia(CAP).Methods 80 adult patients with CAP were randomly divided into a control group and a treatment group,with 40 cases in each group.The control group was treated with traditional Western medicine,and the treatment group was treated with Zhuanglian oral liquid.The improvement degree of clinical symptoms and the effect of drug application in the treat-ment group and the control group were observed,and the blood routine,inflammation-related indexes,and clinical adverse reactions before and after treatment were compared between the two groups.Results The total effective rate of the treatment group was higher than that of the control group(P＜0.05).The disappearance time of main symp-toms such as lung rales and cough in the treatment group was significantly shorter than that in the control group(P＜0.01).Relevant inflammatory indicators after drug treatment in both groups are as follows:The levels of high-sensi-tivity C-reactive protein(hs-CRP),peripheral blood procalcitonin(PCT),serum amyloid A(SAA),neutrophil percentage(Neu％),interleukin-6(IL-6)and white blood cell count(WBC)were significantly decreased(P＜0.05).However,the decrease was more obvious in the treatment group than in the control group(all P＜0.05).There were no adverse reactions during treatment in both groups.Conclusion The combination of Chonglian Oral Liquid and anti-infection has a significant clinical effect in the treatment of adult CAP patients.It can effectively con-trol the pulmonary infection of patients,and can also alleviate the discomfort of patients such as chills,fever,cough,and expectoration,and there are no obvious adverse reactions.It can be popularized and applied in clinical practice.
CAPChonglian Oral Liquidcurative effectinflammatory index
万方数据
维普
